AL-3152

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAL-3152
Drug Alias NameAL-03152
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic NephropathiesDiabetic RetinopathyDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcon
Active IndicationsN/A
Inactive IndicationsDiabetic NephropathiesDiabetic RetinopathyDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A